GLG News Analyses of the following article:
Drug CEOs Switch Tactics on Reform
Published at: online.wsj.com
-
Process of Continuous Improvement and Pharmaceuticals
June 1, 2009
Should the pharmaceutical companies be making an effort to reduce the cost of drugs? I believe that the drug costs are part of the total package and every effort should be made to reduce drug costs.
- Subscribe to Updates
-
Work for one of the world's leading organizations? Get started now.
Get Intelligently Connected
with the world's leading experts
GLG's 850+ Clients Include:
- More than 70% of the world's leading
- mutual funds
- 15 of the leading 20
- global banks
- 9 of the leading 10
- global private equity firms
- 5 of the leading 10
- AmLaw firms
- Fortune 500® Companies
- in nearly every industry sector, including pharmaceuticals, insurance, chemicals, energy and computer software
Gerson Lehrman Group, Inc. connects communities with knowledge through two distinct, yet complementary offerings: GLG Research and G+.